首页> 外文期刊>Cellular immunology >Evaluation of influenza vaccine-immunogenicity in cell-mediated immunity
【24h】

Evaluation of influenza vaccine-immunogenicity in cell-mediated immunity

机译:在细胞介导的免疫中评估流感疫苗的免疫原性

获取原文
获取原文并翻译 | 示例
       

摘要

The immunological effect of influenza vaccines cannot be evaluated accurately using an antibody titer. Therefore, we used a new method that measures cell-mediated immunity to investigate changes in the amount of interferon-gamma (IFN-gamma) produced after vaccination in response to the vaccine antigen. The study was conducted during the 2014-2015 influenza season in 23 adults, using a vaccine that contained three types of antigen. The IFN-gamma level increased by at least 1.5 times in 65% (15/23) of cases in response to the H1N1 antigen, in 57% (13/23) of cases in response to the H3N2 antigen, and in 57% (13/23) of cases in response to the B antigen. During the study period, 4 subjects developed type A influenza. Our data showed that the IFN-gamma level did not increase by 1.5 times in these subjects. We propose that the efficacy of influenza vaccines may be evaluated by measuring changes in the level of IFN-gamma produced in response to influenza vaccine. (C) 2016 Elsevier Inc. All rights reserved.
机译:使用抗体滴度无法准确评估流感疫苗的免疫学效果。因此,我们使用了一种测量细胞介导的免疫力的新方法,以调查疫苗接种后针对疫苗抗原产生的干扰素-γ(IFN-γ)量的变化。该研究是在2014-2015年流感季节期间对23位成年人进行的,其中使用了一种包含三种抗原的疫苗。响应H1N1抗原的病例中,有65%(15/23)的病例中IFN-γ水平提高了至少1.5倍,响应H3N2抗原的病例中有57%(13/23)的病例中,和有57%( 13/23)对B抗原有反应的病例。在研究期间,有4名受试者患上了A型流感。我们的数据表明,这些受试者的IFN-γ水平没有增加1.5倍。我们建议可以通过测量响应流感疫苗产生的IFN-γ水平的变化来评估流感疫苗的功效。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号